Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Stem Cells (Dayton, Ohio)|November 22, 2012
Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathwayKyung-Soon Park, Young Cha, Chun-Hyung Kim, et al.Nature|April 10, 2015
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearanceDohoon Kim, Brian P Fiske, Kivanc Birsoy, et al.The Journal of Clinical Investigation|May 18, 2011
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson diseaseYong-Hee Rhee, Ji-Yun Ko, Mi-Yoon Chang, et al.The Journal of Clinical Investigation|May 8, 2025
NK cell activation and CD4 T cell α4β7 expression are associated with susceptibility to HIV-1Kawthar Machmach, Kombo F N'guessan, Rohit Farmer, et al.Plos Pathogens|January 31, 2025
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadthGina L Griffith, Kawthar Machmach, Ningbo Jian, et al.Nature Communications|January 16, 2020
Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infectionKerri G Lal, Dohoon Kim, Margaret C Costanzo, et al.Viruses|December 16, 2020
Longitudinal Analysis of Peripheral and Colonic CD161+ CD4+ T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment InitiationKerri G Lal, Yuwadee Phuang-Ngern, Suchada Suhkumvittaya, et al.Applied Optics|August 12, 2025
Monolithic trifold flexure aluminum mirror optimized through the response surface method for wide field of view camera applicationsChanggon Kim, Hojae Ahn, Nayeon Kim, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.Pageof 11